Sg3 Management, LLC Ultragenyx Pharmaceutical Inc. Put Options Transaction History

Sg3 Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$36.99 - $48.71 $1.48 Million - $1.95 Million	-40,000 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$39.96 - $66.14 $1.6 Million - $2.65 Million	40,000 New	40,000 $1.66 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $1.6 Million - $2.65 Million	40,000 New	40,000 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $961,799 - $1.79 Million	-21,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $1.31 Million - $1.77 Million	21,000 New	21,000 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $779,200 - $1.02 Million	-10,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $230,475 - $289,275	-2,500 Reduced 20.0%	10,000 $954,000
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $1.06 Million - $2.22 Million	12,500 New	12,500 $1.73 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.37B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.